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Complete nucleotide sequence of the fosfomycin resistance 
transposon Tn2921 
 
Sir, 
Fosfomycin is a cell wall-active antibiotic introduced into clinical practice around 
1970 [1]. Despite its broad spectrum of activity and good pharmacological 
properties, its use has been somehow hampered by the high number of 
spontaneous resistant mutants isolated following antibiotic challenge in many 
bacterial pathogens [2], most of them carrying chromosomal mutations 
impairing drug transport. 
 
Fosfomycin has been used steadily for the treatment of lower urinary tract 
infections. Recently, the emergence of resistance to newer antibiotics has 
resulted in a renewed interest in fosfomycin as a therapeutic agent [3]. 
 
The existence of plasmids conferring resistance to fosfomycin was 
demonstrated in strains of Serratia marcescens isolated in the Hospital ‘Nuestra 
Señora de Covadonga’ (Asturias, Spain) [4]. The fosfomycin resistance gene 
fosA in some of those plasmids was found to reside on a transposable element 
called Tn2921 [5]. The fosA gene was shown to encode a fosfomycin-
inactivating mechanism [6] that consisted of enzymatic coupling with 
glutathione. The transposable element Tn2921 was estimated to be ca. 12.5 kb 
long, but its composition was unknown except for the presence of the fosA gene 
and the two terminal copies of insertion sequence IS2921, which are closely 
related to IS10 (1.3 kb each) [7]. To gain further insight into the gene content of 
 2
Tn2921 and the possible mechanisms leading to the assembly of the 
transposon, the complete nucleotide sequence of Tn2921 in plasmid pSU912 
was determined. The transposon was flanked by identical 1329-bp long 
insertion sequences, with only 1 bp difference from IS10-right (IS10R) and 14 
bp with IS10-left (IS10L). A single sequence of 12 452 bp containing the 
complete 12 434 bp of the transposon and the two target 9-bp direct repeats 
has been deposited in GenBank (accession no. FJ829469). The numbering 
used in the text makes reference to this GenBank entry. 
 
The first open-reading frame (ORF) next to IS10L (1347–1701) contains a 120-
amino acid N-terminal fragment of a tryptophanyl-tRNA synthetase II truncated 
by the insertion of IS10. The 9-mer Tn10 target site sequence GGCGAAGCC 
(1339–1347) signals the limit of the gene remnant and indicates that IS10 was 
integrated here by transposition. 
 
The fosA gene (1901–2326) is the fosfomycin resistance gene. Genes similar to 
fosA are relatively frequent in the chromosomes of many bacteria, where they 
play functions related or not with antibiotic resistance. 
 
Protein BLAST searches identified three complete ORFs in the region (2312–
6033) contiguous to fosA. The first ORF encoded a transcriptional regulator 
belonging to the LacI family. The next encoded a conserved hypothetical protein 
with a possible function as a glycoside hydrolase. The final ORF encodes a 
sugar transporter belonging to the major facilitator superfamily (MFS). This 
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gene arrangement is suggestive of a system operating to sense, transport and 
hydrolyse some sugar molecules for further use in bacterial metabolism. 
 
The next two ORFs in Tn2921 (6068–8172) form part of a 5-methylcytosine 
GTP-dependent restriction system. The mcrC gene is complete, whilst the mcrB 
gene is 5’ truncated and is probably not functional, rendering the mcrC gene 
useless because both proteins are required for function. 
 
The sequence from here to the right end of the transposon consists of nested 
remnants of transposable elements following a ‘transposon in transposon’ 
design type. Next to mcrB (8172–9872), a non-functional fragment of the Tn3 
transposase gene was identified. The sequence from 9874 to 11 114 
corresponded to the left end of the transposon Tn7 including the left IR and the 
carboxyl-terminal end of the site-specific recombinase IntI2. The presence of 
the left IR of the transposon Tn7 suggests that Tn7 could have transposed into 
Tn3. Tn7 was interrupted by integration of IS10R, which constitutes the right 
end of Tn2921 (Fig. 1). 
 
The complete central region of Tn2921 was not syntenic with any sequence 
deposited in the public sequence databases. However, the 5.6 kb DNA region 
between IS10L and the mcr genes, including fosA (1339–5967), showed 90% 
identity with a genomic segment from Enterobacter cancerogenus ATCC 33516 
(GenBank accession no. ABWM00000000). A chromosomal region like this 
could be the origin of the transposon. The deletion of a gene (ENTCAN_00725) 
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and integration of IS10 into ENTCAN_00726 will exactly produce the left half of 
Tn2921 (Fig. 1). 
 
In conclusion, Tn2921 provides a good example of evolution of an antibiotic 
resistance composite transposon. We can assume that an enterobacterial gene 
encoding a protein of the glyoxalase family was deregulated and subsequently 
incorporated as a fosfomycin resistance gene in a transposable element by 
successive integration of two identical ISs. Furthermore, the presence of genes 
unrelated to resistance and of many gene remnants in the central part of 
Tn2921 suggests that this transposon may have evolved recently under the 
selective pressure of fosfomycin usage. 
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Fig. 1. Gene map of transposon Tn2921. Genes that are inactive due to 
truncation are filled with dots. The fosA gene is in black. The lower part of the 
figure shows the segment from the Enterobacter cancerogenus genome that is 
homologous and co-linear with the left half of the transposon (grey blocks). 
Deletion of gene ENTCAN_00725 and insertion of IS10L at the indicated point 
(black arrowhead) of ENTCAN_00726 could be the origin of the transposon. 
Segments from Tn3 and Tn7 are also indicated. 
 
 
